Telithromycin: A Viewpoint by Arthur L. Barry

Barry, A.L.
April 2001
Drugs;Apr2001, Vol. 61 Issue 6, p830
Academic Journal
Provides information on telithromycin, a compound of antibacterial agent called ketolides, indicated for treating infections. Comparison between macrolides and ketolides; Information on erythromycin-resistant Streptococcus pneumoniae strains; Mechanisms of resistance that can result in different levels of resistance to macrolides and lincosamides.


Related Articles

  • Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. R. Anderson; H. C. Steel; R. Cockeran; A. von Gottberg; L. de Gouveia; K. P. Klugman; T. J. Mitchell; C. Feldman // Journal of Antimicrobial Chemotherapy (JAC);Nov2007, Vol. 60 Issue 5, p1155 

    Objectives To compare the effects of subinhibitory concentrations of amoxicillin, ceftriaxone, azithromycin, clarithromycin, erythromycin, telithromycin, clindamycin, ciprofloxacin, moxifloxacin, tobramycin and doxycycline on pneumolysin production by a macrolide-susceptible strain and two...

  • Macrolide Resistance in Streptococcus pneumoniae: Clonality and Mechanisms of Resistance in 24 Countries. Bozdogan, B�lent; Bogclanovich, Tatiana; Kosowska, Klaudia; Jacobs, Michael R.; Appelbaum, Peter C. // Current Drug Targets - Infectious Disorders;Sep2004, Vol. 4 Issue 3, p169 

    The clonality and mechanisms of macrolide resistance were studied among 345 macrolide resistant Streptococcus pneumoniae strains isolated from 24 countries. The mechanisms of macrolide resistance, serotypes and PFGE types of the strains were determined and representative strains of clones from...

  • Evaluation of resistance mechanisms and serotype and genotype distributions of macrolide-resistant strains in clinical isolates of Streptococcus pneumonia in Aydın, Turkey. Telli, Murat; Eyigör, Mete; Gültekin, Berna; Aydın, Neriman // Journal of Infection & Chemotherapy (Springer Science & Business;Oct2011, Vol. 17 Issue 5, p658 

    Macrolide resistance mechanisms in 89 Streptococcus pneumoniae strains isolated from several clinical samples between February 2007 and May 2009 were investigated. Erythromycin resistance was noted in 35 (40%) S. pneumoniae strains. In these strains, the most frequent resistance phenotype was...

  • Genetic Elements Carrying Macrolide Efflux Genes in Streptococci. Pozzi, Gianni; Iannelli, Francesco; Oggioni, Marco R.; Santagati, Maria; Stefani, Stefania // Current Drug Targets - Infectious Disorders;Sep2004, Vol. 4 Issue 3, p203 

    Type M resistance to macrolides in Streptococcus pyogenes and Streptococcus pneumoniae is associated to the presence of macrolide efflux genes (mef). These genes are carried by 3 very conserved chromosomal genetic elements: (i) "mega", 5.5 kb, typical of S. pneumoniae, carries mef(E), can insert...

  • Emergence and Spread of Streptococcus pneumoniae with erm(B) and mef(A) Resistance. Farrell, David J.; Jenkins, Stephen G.; Brown, Steven D.; Patel, Manish; Lavin, Bruce S.; Klugman, Keith P. // Emerging Infectious Diseases;Jun2005, Vol. 11 Issue 6, p851 

    Streptococcus pneumoniae isolates (N = 31,001) were collected from patients with community-acquired respiratory tract infections during the PROTEKT US surveillance study (2000-2003). While the macrolide (erythromycin) resistance rate remained stable at =29%, the prevalence of resistant isolates...

  • ERYTHROMYCINS.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p368 

    The article presents information on antibacterial and antiacne drug erythromycins, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs and substances.

  • Macrolide Resistance from the Ribosome Perspective. Franceschi, F.; Kanyo, Z.; Sherer, E.C.; Sutcliffe, J. // Current Drug Targets - Infectious Disorders;Sep2004, Vol. 4 Issue 3, p177 

    Macrolides are important antibiotics used in treatment of respiratory tract infections in humans. Although some of these compounds have been in use for 50 years, it has not been until the last few years that their mechanism of action and the nature of ribosomal-based resistance could be more...

  • Clinical Pharmacokinetics of Telithromycin, the First Ketolide Antibacterial. Shi, Jun; Montay, Guy; Bhargava, Vijay O. // Clinical Pharmacokinetics;2005, Vol. 44 Issue 9, p915 

    Telithromycin is the first ketolide, which is a new class of antibacterial agents related to the macrolides that have structural modifications permitting dual binding to bacterial ribosomal RNA so that activity is retained against Streptococcus pneumoniae with...

  • Novel Clarithromycin Analogs with C-4" 2-arylbenzimidazolyl Bishydrazide Side Chain: Synthesis and Antibacterial Evaluation. Yunkun Qi; Ruixin Ma; Xin Li; Yue Hu; Siti Ma; Chao Cong; Xiaodong Ma; Wenping Cui; Shutao Ma // Letters in Drug Design & Discovery;Dec2011, Vol. 8 Issue 10, p966 

    A series of novel 4"-O-2-arylbenzimidazolyl derivatives of clarithromycin were synthesized and evaluated. These 4"-O-2-arylbenzimidazolyl derivatives demonstrated excellent activity against erythromycin-susceptible strains and showed remarkably improved activity against erythromycin-resistant...


Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics